![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
CASE REPORT
Chirurgia 2020 February;33(1):51-7
DOI: 10.23736/S0394-9508.19.04942-8
Copyright © 2019 EDIZIONI MINERVA MEDICA
language: English
Bowel perforation complicating sodium polystyrene sulfonate (Kayexalate®) therapy
Moira PELLEGRINELLI 1 ✉, Matteo MARCHESI 2, Osvaldo MORINI 1, Marco LOTTI 3
1 Department of Medicine and Surgery, School of Medicine and Surgery, University of Milan, Milan, Italy; 2 Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Hospital of Bergamo, University of Milan, Bergamo, Italy; 3 Unit of Advanced Surgical Oncology, Department of General Surgery 1, Papa Giovanni XXIII Hospital, Bergamo, Italy
Bowel perforation is an uncommon complication of the administration of sodium polystirene sulfonate. We describe a case of bowel perforation occurring soon after the performance of a right colectomy in a patient with stage 3 chronic renal failure treated with sodium polystyrene sulfonate. The perforation was revealed during the course of revision surgery. Histological examination demonstrated perivisceritis with ischemic wall damage and hemorrhagic mucosa filled with numerous blackish, sharp-angled crystalloids. After reviewing the literature concerning the complications associated with the administration of SPS, we discuss some aspects of professional medical liability with particular reference to the etiopathogenesis of bowel perforation.
KEY WORDS: Intestinal perforation; Polystyrene sulfonic acid; Sorbitol; Hyperkalemia